HE4-test of urine and body fluids for diagnosis of gynecologic cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HE4-test of urine and body fluids for diagnosis of gynecologic cancer
Authors
Keywords
-
Journal
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
Volume 17, Issue 3, Pages 239-244
Publisher
Informa UK Limited
Online
2017-01-25
DOI
10.1080/14737159.2017.1282824
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association of Serum HE4 with Primary Tumor Diameter and Depth of Myometrial Invasion in Endometrial Cancer Patients at Rajavithi Hospital
- (2016) Nisa Prueksaritanond et al. Asian Pacific Journal of Cancer Prevention
- Physiopathological factors affecting the diagnostic value of serum HE4-test for gynecologic malignancies
- (2016) Wanglei Qu et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Alternative tumor markers in the diagnosis of ovarian cancer
- (2016) Burcu Kısa Karakaya et al. Ginekologia Polska
- Comparison of Serum Human Epididymis Protein 4 and Carbohydrate Antigen 125 as Markers in Endometrial Cancer
- (2016) Lingli Hu et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms: Clinical correlates
- (2015) John B. Liao et al. GYNECOLOGIC ONCOLOGY
- Expression and Diagnostic Value of HE4 in Pancreatic Adenocarcinoma
- (2015) Tianhe Huang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The role of HE4 in endometrial cancer recurrence: how to choose the optimal follow-up program
- (2015) Roberto Angioli et al. TUMOR BIOLOGY
- HE4 Tissue Expression and Serum HE4 Levels in Healthy Individuals and Patients with Benign or Malignant Tumors: A Systematic Review
- (2014) N. S. Karlsen et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Can HE4 predict platinum response during first-line chemotherapy in ovarian cancer?
- (2014) Roberto Angioli et al. TUMOR BIOLOGY
- HE4 (WFDC2) gene overexpression promotes ovarian tumor growth
- (2014) Richard G. Moore et al. Scientific Reports
- Borderline Ovarian Tumors and Diagnostic Dilemma of Intraoperative Diagnosis: Could Preoperative He4 Assay and ROMA Score Assessment Increase the Frozen Section Accuracy? A Multicenter Case-Control Study
- (2014) Salvatore Gizzo et al. Biomed Research International
- Urinary Concentrations of Human Epidydimis Secretory Protein 4 (He4) in The Diagnosis of Ovarian Cancer: A Case-Control Study
- (2013) Ronalds Macuks et al. Asian Pacific Journal of Cancer Prevention
- Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis: a systematic review
- (2013) Simona Ferraro et al. JOURNAL OF CLINICAL PATHOLOGY
- The utility of isotope-coded protein labeling for prioritization of proteins found in ovarian cancer patient urine
- (2013) Adam Rainczuk et al. JOURNAL OF PROTEOME RESEARCH
- Human Epididymis Protein 4 and Secretory Leukocyte Protease Inhibitor in Vaginal Fluid
- (2013) Theofano Orfanelli et al. Reproductive Sciences
- Human epididymis protein 4 (HE4) in benign and malignant diseases
- (2012) Linda Hertlein et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Immunohistochemical Localization of HE4 in Benign, Borderline, and Malignant Lesions of the Ovary
- (2012) Penelope Georgakopoulos et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- In-depth analysis of the human tear proteome
- (2012) Lei Zhou et al. Journal of Proteomics
- Human Epididymis Protein-4 (HE-4): A Novel Cross-Class Protease Inhibitor
- (2012) Nirmal Chhikara et al. PLoS One
- Serum Human Epididymis Protein 4 and Risk for Ovarian Malignancy Algorithm as New Diagnostic and Prognostic Tools for Epithelial Ovarian Cancer Management
- (2011) E. Bandiera et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases
- (2011) J. M. Escudero et al. CLINICAL CHEMISTRY
- The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful?
- (2011) Martina Montagnana et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Integration of cell phone imaging with microchip ELISA to detect ovarian cancer HE4 biomarker in urine at the point-of-care
- (2011) ShuQi. Wang et al. LAB ON A CHIP
- HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases
- (2011) Rafael Molina et al. TUMOR BIOLOGY
- Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms
- (2010) Ingegerd Hellstrom et al. CANCER LETTERS
- Influence of Ovarian Cancer Risk Status on the Diagnostic Performance of the Serum Biomarkers Mesothelin, HE4, and CA125
- (2009) C. A. Shah et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Three new potential ovarian cancer biomarkers detected in human urine with equalizer bead technology
- (2008) Anette Lykke Petri et al. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
- Tracheobronchial air-liquid interface cell culture: a model for innate mucosal defense of the upper airways?
- (2008) Mehmet Kesimer et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus
- (2008) Richard G. Moore et al. GYNECOLOGIC ONCOLOGY
- A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
- (2008) Richard G. Moore et al. GYNECOLOGIC ONCOLOGY
- Extensive fractionation and identification of proteins within nasal lavage fluids from allergic rhinitis and asthmatic chronic rhinosinusitis patients
- (2008) Linda M. Benson et al. JOURNAL OF SEPARATION SCIENCE
- The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass
- (2007) Richard G. Moore et al. GYNECOLOGIC ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started